Synapsoft logo
AI Insights from Disclosures
Searching...
DONG-A ST CO.,LTD 170900
Searching...

Company Summary

Quarterly Performance Revenue Operating Margin

Market Sentiment

※ Click the graph to view AI analysis information for that month.
Revenue
Consolidated
Separate
Operating Income
Consolidated
Separate
Net Income
Consolidated
Separate

Financials

Excel

No financial data is available for this period.
~
Quarterly
Annual
No data is available for this period.

*Values beyond the fourth decimal place of the unit are displayed as '0/-0'

Financial Indicator Forecast

※ These forecasts are simple AI estimates based on historical data and may differ from actual results.

Company Overview

as of June 2026
DONG-A ST CO.,LTD was established through a spin-off from Dong-A Socio Holdings Co., Ltd. (formerly Dong-A Pharmaceutical Co., Ltd. before the spin-off), with the spin-off date of March 1, 2013, for the purpose of manufacturing and selling prescription drugs, medical devices, and quasi-drugs, and its main business is the manufacture and sale of prescription drugs and other products. The company manufactures and sells its own developed new drugs such as Stillen, Zydena, Motilitone, and Suganon, as well as various prescription drugs (ETC) such as Growtropin and Gaster, and produces various products at its Cheonan, Daegu, and Songdo campuses.
Representative Director Jung Jaehun
Founded March 4, 2013
Corporation Type KOSPI
Industry Classification Manufacture of medicaments
Corporate number 11011-5079713
Business number 204-86-40122
Phone Number 02-920-8114
Fax Number 02-923-1202
Website www.donga.co.kr
Company Address 서울 동대문구 용두동 138 ~255 천호대로 64
Products & Services

Financial Health

Executives

Employees

Shareholders

Industry revenue

Disclosures

Comments

0 / 255

AI Assistant